Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0PY3L
|
||||
Former ID |
DNCL002165
|
||||
Drug Name |
MEDI-565
|
||||
Drug Type |
Monoclonal antibody
|
||||
Indication | Gastrointestinal adenocarcinoma [ICD10:C15-C26] | Phase 1 | [523334] | ||
Company |
MedImmune
|
||||
Target and Pathway | |||||
Target(s) | CD3 | Target Info | Modulator | [889442] | |
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | T cell activation | ||||
Reactome | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | ||||
Phosphorylation of CD3 and TCR zeta chains | |||||
Translocation of ZAP-70 to Immunological synapse | |||||
Generation of second messenger molecules | |||||
FCGR activation | |||||
Regulation of actin dynamics for phagocytic cup formation | |||||
Role of phospholipids in phagocytosis | |||||
PD-1 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.